• EZ Cap™ Cas9 mRNA (5-moUTP) Workflow

  2026-09-28

  Build transient CRISPR-Cas9 genome editing workflows for zebrafish and cell-based functional gene studies with a capped, modified Cas9 mRNA. This guide connects the Fyn–Stat3 neurodegeneration model to practical delivery, controls, optimization, and troubleshooting without overstating what the reference study demonstrated.

• Masitinib (AB1010): KIT/PDGFR Workflow Guide

  2026-09-28

  Masitinib (AB1010) is a DMSO-compatible kinase inhibitor for research requiring targeted study of KIT and PDGFRα/β, including KIT-mutant cell models and mast cell assays. It is not suited to aqueous or ethanol-based workflows, broad-spectrum kinase inhibition, or clinical treatment decisions; establish cellular working conditions in the specific assay rather than transferring biochemical values directly.

• Reversine and the Mitotic Checkpoint: A Research Guide

  2026-09-27

  Reversine is an Aurora kinase inhibitor for probing mitotic control and cancer cell responses. This guide connects Aurora kinase perturbation with mitotic checkpoint-complex research while clarifying what the evidence does—and does not—show.

• Cl-Amidine Workflows for PAD4 Research

  2026-09-26

  Use Cl-Amidine to probe PAD4-dependent citrullination with a controlled, dose-ranging workflow—not as a presumed modifier of ribotoxic-stress signaling. This guide covers practical assay setup, disease-model applications, and controls that help distinguish PAD4 target engagement from broader cell-stress effects.

• Dabigatran Workflows for Coagulation Research

  2026-09-25

  Use Dabigatran to probe direct thrombin inhibition across purified-enzyme assays and plasma clotting tests, with concentration ranges that support dose-response comparisons. This guide connects bench workflows to the clinical evidence for Pradaxa while emphasizing solubility checks, matched controls, and assay-specific interpretation.

• HRP Goat Anti-Rabbit IgG: From Signal to Evidence

  2026-09-25

  See how Affinity-Purified Goat Anti-Rabbit IgG (H+L) supports protein detection—and how careful assay design turns a band or stain into interpretable evidence. Using a study of Ephx2 in hypertensive rat cavernous tissue, this article connects secondary-antibody choice to validation strategy.

• CF10–EdU Synergy Drives Telomere Attrition in CRC

  2026-09-24

  The study reports that the fluoropyrimidine polymer CF10 synergizes with EdU in colorectal cancer cells, whereas EdU plus 5-fluorouracil showed only additivity in the tested conditions. The results connect enhanced EdU incorporation and DNA damage with telomere-signal loss and abnormal mitosis, offering a mechanistic basis for further preclinical investigation—not evidence of clinical efficacy.

• HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody

  2026-09-24

  Learn how SKU K1205 can support human IgG detection across immunofluorescence, flow cytometry, Western blotting, and related assays—without confusing antibody staining with a direct cell-viability readout. This scenario-led guide covers assay controls, optimization, storage, and the limits of applying a human-specific secondary to animal-model samples.

• Baicalin: Designing Experiments Beyond the Headline

  2026-09-23

  Baicalin reactivated adult visual-cortex plasticity in a mouse study, but the result depends on dose, behavioral context, and how plasticity is measured. This article turns that finding into a practical framework for distinguishing evidence, choosing assays, and handling the compound reliably.

• HotStart™ 2X Green qPCR Master Mix Guide

  2026-09-23

  Learn how HotStart™ 2X Green qPCR Master Mix, SKU K1070, can strengthen gene-expression measurements that support cell viability, proliferation, and cytotoxicity studies. This scenario-driven guide covers assay design, SYBR Green specificity, protocol controls, data interpretation, and practical reagent selection.

• ETS1–SENP2 Axis in Bronchopulmonary Dysplasia

  2026-09-22

  This 2026 study identifies ETS1 as a transcriptional regulator that protects against hyperoxia-induced bronchopulmonary dysplasia by coordinating the SENP2/HSPA8/FUNDC1 pathway. Its central contribution is to connect FUNDC1 SUMO1 modification, chaperone-mediated degradation, mitochondrial damage, and excessive mitophagy with alveolar developmental injury.

• Measuring Drug Response Beyond Relative Viability

  2026-09-22

  Hannah R. Schwartz’s 2022 dissertation argues that relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. By separating growth inhibition from cell killing and considering their different timing, the work provides a practical framework for interpreting in vitro drug responses more accurately.

• Patient-Derived Gastric Cancer Assembloids

  2026-09-21

  The reference study develops patient-specific gastric cancer assembloids by combining matched tumor organoids with tumor-derived stromal cell subpopulations. Its results show that stromal composition changes gene expression and drug sensitivity, supporting more physiologically relevant studies of tumor biology, resistance, and personalized treatment strategies.

• Alcian Blue & Nuclear Fast Red Staining Kit Guide

  2026-09-21

  Learn how to apply dual staining for acid mucins, mucopolysaccharides, and chondrogenic differentiation while preserving nuclear contrast. This practical guide combines a small-biopsy visibility study with workflow, optimization, and troubleshooting recommendations for reproducible research staining.

• CD38 CAR Binder Structures and Affinity Tuning

  2026-09-20

  Cheng et al. dissect how two CD38-targeting CAR binders recognize the antigen, showing that RP02 and 028 use distinct epitopes and that 028 can inhibit CD38 enzymatic activity through structural occlusion. The study further demonstrates that the affinity-attenuated 028R103G CAR reduces fratricide while preserving cytotoxicity, providing a structure-guided framework for balancing tumor activity and cellular selectivity.

8512 records 2/568 page Previous Next 12345 下5页 Last page